Experienced in Colitis

Lei H. Cheng

83 FenYang Road, 
Shanghai, CN 
Experienced in Colitis
83 FenYang Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Lei Cheng practices in Shanghai, China. Ms. Cheng is rated as an Experienced expert by MediFind in the treatment of Colitis. Her top areas of expertise are Allergic Rhinitis, Leukoplakia, Thrush, Laryngectomy, and Posterior Fossa Decompression.

Her clinical research consists of co-authoring 1067 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Colitis.

Gender
Female

Locations

83 FenYang Road, Shanghai, 200031, China
Other Locations
305 Fenglin Road, Shanghai, 200032, China
No. 300 Guangzhou Road, Nanjing, 210029, China
Huaihai West Road No.241, Huaihai, 200030, China
NO.725, South Wanping Road, Xuhui, 200032, China
No. 507, Zheng Min Road, Shanghai, 200433, China
45 Changchun Street, Beijing, 100053, China
Renmin South Road, Chengdu, 610041, China
45 Changchu Street, Beijing, 100053, China
1 Banshandong Road, Hangzhou, 310022, China
29 Wangjiang Road, Chengdu, 610064, China
State Key Laboratory Of Bioreactor Engineering, Shanghai, 200237, China
No. 321 Zhongshan Road, Nanjing, 210008, China
11 & 33 Fu Cheng Road, Haidian, 100048, China
321 Zhongshan Road, Nanjing, 210008, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
Enrollment Status: Completed
Publish Date: November 25, 2024
Intervention Type: Drug
Study Drugs: Mepolizumab, Standard of Care
Study Phase: Phase 3

1067 Total Publications

COL5A1 in the tumor microenvironment predicts the prognosis of head and neck cancer.
COL5A1 in the tumor microenvironment predicts the prognosis of head and neck cancer.
Journal: Science progress
Published: November 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cheng's expertise for a condition
ConditionClose
    View All 18 Advanced Conditions
    View All 86 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile